Welcome to the e-CCO Library!

P018: Macrophage targeting contributes to the inhibitory effects of dihydroartemisinin on DSS-induced colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. Teng*1, W. Ting1, W. Huahong1

Created: Friday, 22 February 2019, 9:41 AM
P018: Myeloid diversity in inflammatory bowel disease revealed by single-cell transcriptomics
Year: 2021
Source: ECCO'21 Virtual
Authors: Garrido Trigo, A.(1);Corraliza, A.M.(1);Melón-Ardanaz, E.(1);Veny, M.(1);Ordás, I.(2);Ricart, E.(2);Masamunt, M.C.(2);Panès, J.(2);Hemberg, M.(3);Mereu, E.(4);Heyn, H.(5);Azucena, S.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P018: Proteomic profile of serum and urine in newly diagnosed patients with Inflammatory Bowel Disease: new approach for biomarker discovery
Year: 2022
Source: ECCO'22
Authors: Baldan-Martin, M.(1);Azkargorta , M.(2);Iloro , I.(2);Ortega Moreno , L.(1);Aldars Garcia , L.(1);Soleto Fernández , I.(1);Ramirez , C.(1);Riestra , S.(3);Rivero , M.(4);Gutierrez , A.(5);Rodríguez-Lago , I.(6);Fernández-Salazar , L.(7);Ceballos , D.(8);Benítez , J.M.(9);Aguas , M.(10);Bastón-Rey , I.(11);Bermejo , F.(12);Casanova , M.J.(1);Llorente , R.(13);Ber , Y.(14);Royo , V.(15);Esteve , M.(16);Elortza , F.(2);Chaparro , M.(1);Gisbert , J.P.(1);
Created: Friday, 11 February 2022, 3:52 PM
P018: Should NUDT genotyping be tested routinely prior to commencement of thiopurine therapy in Asian patients?
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Shah, M. Paradkar, D. Desai*, T. Ashavaid

Created: Thursday, 21 February 2019, 9:14 AM
P019 Colonic mucosal kinase activity, cytokine and chemokine profiles in inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Brand1, B. Roosenboom2, B. Malvar Fernandez3, L. Lutter1, E. van Koolwijk4, E.G. van Lochem4, C.S. Horjus Talabur Horje2, K.A. Reedquist3, F. van Wijk3, B. Oldenburg5

Created: Thursday, 30 January 2020, 10:12 AM
P0190: Hypoglycemia induces SLC7A11-dependent disulfidptosis to regulate intestinal inflammation in IBD
Year: 2025
Source: ECCO'25
Authors: Chenx7x7x7 C.(1)*;Taox7x7x7 M.(2);Fux7x7x7 Y.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0191: The role of myeloid mineralocorticoid receptor and its target neutrophil gelatinase-associated lipocalin in mice with colitis.
Year: 2025
Source: ECCO'25
Authors: Rebollox7x7x7 E.(1)*;Lebouttex7x7x7 M.(1);Jaisser x7x7x7 F.(2);Savoyex7x7x7 G.(3);Marion-Letellierx7x7x7 R.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0192: Activities of Sorghum bicolor diet on microbial gut-brain axis during experimental Crohn’s Colitis in adult male Wistar rats.
Year: 2025
Source: ECCO'25
Authors: SalamiPhDx7x7x7 A.T.(1)*;Akpamux7x7x7 U.(2);Anyakudox7x7x7 G.C.(3);Oluwakoredex7x7x7 T.S.(3);Olujimi x7x7x7 A.O.(3);Olaleyex7x7x7 B.S.(3);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0193: Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice
Year: 2025
Source: ECCO'25
Authors: Daix7x7x7 D.(1);Fangx7x7x7 C.(2)*;Hongbox7x7x7 C.(2);Xichaox7x7x7 X.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0194: Osteoporosis and osteopenia as extraintestinal manifestations in ulcerative colitis
Year: 2025
Source: ECCO'25
Authors: Andronic x7x7x7 A.M.(1);Andronic x7x7x7 C.(2);Toader x7x7x7 E.(2)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0195: Immune reconstitution following autologous hematopoietic stem cell transplantation with cyclophosphamide-free mobilization for refractory Crohn’s disease
Year: 2025
Source: ECCO'25
Authors: Saagerx7x7x7 E.(1)*;Lutterx7x7x7 L.(2);Mahmmodx7x7x7 N.(3);Hoytema van Konijnenburgx7x7x7 D.(4);Delemarrex7x7x7 E.(1);van der Walx7x7x7 M.(1);Oldenburgx7x7x7 B.(5);van Wijkx7x7x7 F.(1);Fidderx7x7x7 H.(5);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0196: Metabolic dysregulation in Crohn’s disease fibrosis: Targeting WISP1 to restore ECM homeostasis
Year: 2025
Source: ECCO'25
Authors: Buckx7x7x7 A.(1x7x7x72)*;Widemannx7x7x7 K.(1);Weberx7x7x7 M.C.(1);Friessx7x7x7 H.(1);Neumannx7x7x7 P.A.(1x7x7x72);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0197: Comparison of pharmacodynamic and mechanistic response of guselkumab intravenous and subcutaneous induction in moderately to severely active Crohn’s disease: molecular analysis of the GRAVITI and GALAXI Phase 3 studies
Year: 2025
Source: ECCO'25
Authors: Richardsx7x7x7 D.(1)*;Patelx7x7x7 R.(1);Sohnx7x7x7 K.(1);Hartx7x7x7 A.(1);Leex7x7x7 T.(1);Liux7x7x7 J.(1);Siskx7x7x7 C.(1);Olurindex7x7x7 M.(1);Terryx7x7x7 N.(1);McRaex7x7x7 B.(1);Reinischx7x7x7 W.(2);Feaganx7x7x7 B.(3);Steinwurzx7x7x7 F.(4);Panaccionex7x7x7 R.(5);D’Haensx7x7x7 G.(6);Braniganx7x7x7 P.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0198: Comparative Transcriptomic Analysis of Tonsil-derived and Adipose-derived Mesenchymal Stem Cells: Proliferationx7x7x7 Migrationx7x7x7 and Anti-inflammatory Potential in Murine Colitis Model
Year: 2025
Source: ECCO'25
Authors: Songx7x7x7 E.M.(1)*;Joox7x7x7 Y.H.(1);Byeonx7x7x7 J.(1);Choex7x7x7 A.R.(1);Parkx7x7x7 Y.(1);Taex7x7x7 C.H.(1);Kimx7x7x7 S.E.(1);Jungx7x7x7 H.K.(1);Shimx7x7x7 K.N.(1);Jungx7x7x7 S.A.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0199: Development of a high-throughput multiplex immunofluorescence and an AI-assisted image analysis tool to study T cells dynamics in pre-clinical rodent models of IBD
Year: 2025
Source: ECCO'25
Authors: Pretix7x7x7 M.(1)*;Hofvingx7x7x7 T.(1);Bretinx7x7x7 A.(1);Benonissonx7x7x7 H.(1);Gonzalez-King Garibottix7x7x7 H.(1);Burguenox7x7x7 J.(1);Bordex7x7x7 A.(1);Birrelx7x7x7 M.(2);Preitex7x7x7 S.(1);Pirasx7x7x7 A.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P019: Anti-TNF-alpha therapy induces microbial and immunological changes in dextran sodium sulphate chronic colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Petito V.*1, Graziani C.1, Lopetuso L.1, Quaranta G.2, Paroni Sterbini F.2, Masucci L.2, Sgambato A.3, Cammarota G.1, Sanguinetti M.2, Gasbarrini A.1, Scaldaferri F.1

Created: Wednesday, 20 February 2019, 10:36 AM
P019: Differential effects of first-line IFX and conventional treatment on inflammatory serum proteins of paediatric moderate- to-severe Crohn’s disease patients.
Year: 2021
Source: ECCO'21 Virtual
Authors: JongsmaMSc, M.(1);Costes, L.M.M.(2);Tindemans, I.(2);Cozijnsen, M.A.(1);Raatgeep, R.H.C.(2);van Pieterson, M.(1);Li, Y.(3);Escher, J.C.(1);de Ridder, L.(1);Samsom, J.N.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P019: GS-1069518 is a potent and selective small molecule α4β7 inhibitor
Year: 2022
Source: ECCO'22
Authors: Wang, Y.(1);Zhou, J.(2);Chang, C.(3);Roedder, S.(3);Bonne-Annee, S.(1);Marchand, B.(4);Hung, K.(4);Currie, K.(5);Clarke, A.(1);
Created: Friday, 11 February 2022, 3:52 PM
P019: Host-Enterobacteriaceae interactions and mitochondrial dysfunction in Crohn's colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Holani, R.(1)*;Bar-Yoseph, H.(2);Krekhno, Z.(3);Moon, K.M.(4);Stacey, R.G.(4);Serapio-Palacios, A.(3);Bressler, B.(5);Donald, K.(6);Foster, L.J.(7);Finlay, B.B.(3);
Created: Friday, 14 July 2023, 10:48 AM
P019: Informing ulcerative colitis pathophysiology and outcomes through metabolic pofiling
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Fong*1, C. Le Roy2, J. Sanderson1, S. Claus2

Created: Friday, 22 February 2019, 9:49 AM